Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured and underinsured individuals to be able to pay cash for its weight loss product Wegovy at a significantly reduced cost. The drugmaker has named its new program NovoCare® Pharmacy, which will sell all dose strengths of Wegovy at $499...
The Associated PressHome bakers donate fresh bread to food banks thanks to this Seattle nonprofitA Seattle-area nonprofit group called Community Loaves donates home-baked bread and cookies to food banks in four states23 minutes ago
- today, 8:54 AM
- abcnews.go.com
- 0
No comments